AXSM

Latest SEC Filings & News for AXSM

3 most recent filings and news items mentioning AXSM. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day
curl "https://api.brieftape.com/v1/tickers/AXSM/news?limit=20"

Pull AXSM filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day

Axsome Therapeutics establishes executive severance and change in control plan

Axsome Therapeutics adopted an Executive Severance and Change in Control Plan effective June 5, 2026, to provide severance benefits to key employees upon involuntary termination. The plan supersedes prior severance arrangements and is intended to retain executive talent during or

View filing at SEC.gov →

10 Health Care Stocks Whale Activity In Today's Session

10 Health Care Stocks Whale Activity In Today's Session

View filing at SEC.gov →

Axsome settles all SUNOSI patent litigation, grants generic entry from 2040

Axsome Therapeutics resolved all patent litigation related to SUNOSI (solriamfetol) by settling with the remaining first-to-file generic applicant, allowing five companies to sell generic versions starting September 1, 2040 (or March 1, 2040 if no pediatric exclusivity). The sett

View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.